Titlebook: Liver Cancers; From Mechanisms to M Tim Cross,Daniel H. Palmer Book 2019 Springer Nature Switzerland AG 2019 Hepatocellular Carcinoma.Chola

clannish

書目名稱Liver Cancers影響因子(影響力)




書目名稱Liver Cancers影響因子(影響力)學科排名




書目名稱Liver Cancers網(wǎng)絡公開度




書目名稱Liver Cancers網(wǎng)絡公開度學科排名




書目名稱Liver Cancers被引頻次




書目名稱Liver Cancers被引頻次學科排名




書目名稱Liver Cancers年度引用




書目名稱Liver Cancers年度引用學科排名




書目名稱Liver Cancers讀者反饋




書目名稱Liver Cancers讀者反饋學科排名

惰性氣體

Mechanisms of Disease: The Damaged Genome in HCCevelopment, mechanisms of genome injury in HCC and the findings of large-scale sequencing projects in HCC that have transformed our understanding of the pathogenesis. We will also explore the role of DNA-methylation changes in HCC and how they provide complementary information to coding DNA changes.

biopsy

Toxoid-Vaccines

Book 2019and didactic style, this volume includes summaries of the key learning points and questions so that the reader can gauge their knowledge and understanding...This book is aimed to broaden the knowledge base of primary care physicians, general physicians along with specialists in hepatology, oncology and hepato-biliary surgery.

情感

The Role of Interventional Radiology and Image-Guided Ablation in Primary Liver Cancere interventional radiologist’s armamentarium, there are few lesions which cannot be treated percutaneously—it is therefore paramount that referral for image-guided ablation is considered in patients who cannot be treated surgically.

FELON

Book 2019 with diagnosis and current management options together with exploration of future treatment strategies and areas of controversy.?? Furthermore, the book highlights management of the common secondary malignancies and touches on benign liver tumours and how to best manage these.??.Written in a clear

可觸知

non-specialists.Contains summary boxes to highlight the key.This book explores in detail the primary liver cancers of hepatocellular carcinoma and cholangiocarcinoma examining the pathogenesis of disease along with diagnosis and current management options together with exploration of future treatme

厚顏無恥

沒血色

CYT